"Generic Ozempic" Doesn't Exist: The GLP-1 Marketing Claims Regulators Are Targeting

2026-07-20 · CompliancePilotAI.io

Medical weight loss is the fastest-growing service line in aesthetics — and the most actively policed marketing category in the industry. If your practice offers compounded GLP-1 medications, the words on your website matter as much as the medication itself.

The core problem: equivalency claims

A compounded semaglutide or tirzepatide preparation is not a generic drug. There is no FDA-approved generic of Ozempic, Wegovy, Zepbound, or Mounjaro. A compounded formulation is a legally distinct, unapproved product prepared for an individual patient — and the FDA has publicly warned consumers and providers about compounded semaglutide.

That makes these phrases hazardous:

Each one invites two problems at once: a deceptive-advertising theory from the FTC, and a trademark problem with brand manufacturers, who have actively pursued clinics and telehealth platforms over exactly this language.

The second problem: borrowed evidence

Brand-name GLP-1s earned their headline statistics — like substantial average body weight reduction — in trials of those specific products. Quoting those numbers to market a compounded program borrows substantiation your product doesn't have. The FTC's standard is simple: health claims need competent and reliable scientific evidence for the product you're actually selling.

What compliant GLP-1 marketing looks like

"We offer physician-supervised medical weight-management programs, which may include prescription medication where clinically appropriate. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Individual results vary."

Notice what this does: it leads with supervision, discloses the compounded status honestly, and promises nothing measurable. Practices worry this language won't sell — in practice, patients searching for medical weight loss respond to physician oversight, and honesty here is also a differentiator when competitors get warning letters.

Quick self-check

Search your website and social captions for: generic, same as, same active ingredient, brand names next to the word compounded, and any percentage weight-loss figure. Every hit needs a rewrite or a removal.

This article is educational content about publicly available regulatory guidance. It is not legal advice; consult healthcare counsel for guidance specific to your practice.

Wondering if your website says any of this?

Run a free AI compliance scan — your score and sample findings in about a minute.

Analyze My Website — Free